Driven by demographic trends, such as an increasing aged population, the global ophthalmic pharmaceutical market is set to become a serious growth area experiencing a compound annual growth rate of 11.11 per cent to 2012.
This report explains just how this market will experience growth over the medium term future. Also do you know what the drivers and restraints of the market are? This report not only reveals these, but also details what strategies can be used to maximize profits from the drivers and restraints.
The Ophthalmic pharmaceutical market is divided into six major diseases.
These are:
Glaucoma
Age-related macular degeneration
Dry eye syndrome
Ocular allergy
Ocular inflammation
Ocular infection
In this report each one of these disease areas is examined in terms of market growth and revenue, current and future drug treatments, market analysis, and major companies involved.
According to the findings of this new 175+ page report, visiongain reveals that Glaucoma therapies are set to dominate the market over the forecast period (2007-2012), accounting for over 40 per cent of market revenues by 2012. Pfizer's product Xalatan, used to lower intraocular pressure to treat glaucoma, will generate blockbuster revenues in 2007, and continue to dominate the entire ophthalmic pharmaceutical market. However are there any others which can compete with this for market share or beat its dominance?
This report answers that question, with an analysis of other players in the market.
- Do you know what the market values of these major therapeutic areas of the ophthalmic world market are?
The report provides in-depth market analysis upon these areas, and extensively identifies both prescription and OTC ophthalmic drugs by disease and product type. The study also assess' the challenges faced by ophthalmic companies, and what exciting market opportunities exist in this up- and-coming therapeutic area.
Why You Must Buy This Report:
This report features over 50 tables, 20 graphs and charts, news, insights, the latest developments and an in depth survey of the opthalmic market with up-to-date analysis. This report is a vital addition to gaining an understanding of this highly profitable market sector and will give your company 'the edge' on your competitors. You can not afford to be without this latest report from visiongain.
With an increasing aged population and unmet medical needs this market is set to grow rapidly, but by how much? This report will tell you. Brought together in one easy to read, easily digested format, this report will keep you fully informed and up-to-date on the global ophthalmic pharmaceutical market.
Key questions that this report answers:
Which current or future therapies will drive the ophthalmic market?
The key companies involved in the market and their analysis?
What R&D opportunities exist for 'new comers'?
What are the current and future blockbusters within the ophthalmic industry?
Unique benefits to you when you order this report:
Immediate access through our exclusive Reading Room
You can access your report whichever country you are in without using harddrive space
Primary research throughout. You will not find this information anywhere else
Report stored in your reading room for ever
Full searchable report when you buy the company or corporate editions
Copies can be printed off for offline reading
Packed with charts, analysis, figures, graphs and tables
Please Note: Reports are sold based on the user licenses indicated. The Publisher delivers the report in Flash format via the publisher website, allowing viewing and printing capabilities only. Within one to two business days after placing the order, the Publisher will email the client with information on accessing their purchase. Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
(0 items)
